Mucosal Vaccines: Recent Progress in Understanding the Natural Barriers

被引:74
作者
Borges, Olga [1 ,2 ]
Lebre, Filipa [1 ,2 ]
Bento, Dulce [1 ,2 ]
Borchard, Gerrit [3 ]
Junginger, Hans E. [4 ]
机构
[1] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3005548 Coimbra, Portugal
[2] Univ Coimbra, Fac Pharm, P-3005548 Coimbra, Portugal
[3] Univ Geneva, Sch Pharmaceut Sci Geneva Lausanne, CH-1211 Geneva 4, Switzerland
[4] Naresuan Univ, Fac Pharmaceut Sci, Phitsanulok 65000, Thailand
关键词
adjuvants; immunoglobulin A; mucosal immune system; mucosal vaccines; B SURFACE-ANTIGEN; NF-KAPPA-B; CELL-MEDIATED-IMMUNITY; HEPATITIS-B; DENDRITIC CELLS; PLG MICROPARTICLES; CPG-DNA; INTRANASAL IMMUNIZATION; DELIVERY-SYSTEMS; PEYERS-PATCHES;
D O I
10.1007/s11095-009-0011-3
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
It has long been known that protection against pathogens invading the organism via mucosal surfaces correlates better with the presence of specific antibodies in local secretions than with serum antibodies. The most effective way to induce mucosal immunity is to administer antigens directly to the mucosal surface. The development of vaccines for mucosal application requires antigen delivery systems and immunopotentiators that efficiently facilitate the presentation of the antigen to the mucosal immune system. This review provides an overview of the events within mucosal tissues that lead to protective mucosal immune responses. The understanding of those biological mechanisms, together with knowledge of the technology of vaccines and adjuvants, provides guidance on important technical aspects of mucosal vaccine design. Not being exhaustive, this review also provides information related to modern adjuvants, including polymeric delivery systems and immunopotentiators.
引用
收藏
页码:211 / 223
页数:13
相关论文
共 131 条
[1]
Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO
[2]
2-U
[3]
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[4]
IMMUNE-RESPONSE TO NASAL DELIVERY OF ANTIGENICALLY INTACT TETANUS TOXOID ASSOCIATED WITH POLY(L-LACTIC ACID) MICROSPHERES IN RATS, RABBITS AND GUINEA-PIGS [J].
ALMEIDA, AJ ;
ALPAR, HO ;
BROWN, MRW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (03) :198-203
[5]
ALMEIDA JD, 1975, LANCET, V2, P899
[6]
Involvement of ERK, p38 and NF-κB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells [J].
An, HZ ;
Yu, YH ;
Zhang, MH ;
Xu, HM ;
Qi, RZ ;
Yan, XY ;
Liu, SX ;
Wang, WY ;
Guo, ZH ;
Guo, J ;
Qin, ZH ;
Cao, XT .
IMMUNOLOGY, 2002, 106 (01) :38-45
[7]
TRANSMUCOSAL PASSAGE OF POLYALKYLCYANOACRYLATE NANOCAPSULES AS A NEW DRUG CARRIER IN THE SMALL-INTESTINE [J].
APRAHAMIAN, M ;
MICHEL, C ;
HUMBERT, W ;
DEVISSAGUET, JP ;
DAMGE, C .
BIOLOGY OF THE CELL, 1987, 61 (1-2) :69-76
[8]
Modulation of immune response to group C meningococcal conjugate vaccine given intranasally to mice together with the LTK63 mucosal adjuvant and the trimethyl chitosan delivery system [J].
Baudner, BC ;
Morandi, M ;
Giuliani, MM ;
Verhoef, JC ;
Junginger, HE ;
Costantino, P ;
Rappuoli, R ;
Del Giudice, G .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (05) :828-832
[9]
BUDKOWSKA A, 1977, J IMMUNOL, V118, P1300
[10]
Cano-Cebrian Maria Jose, 2005, Current Drug Delivery, V2, P9, DOI 10.2174/1567201052772834